Literature DB >> 18343170

Transitions between epithelial and mesenchymal states in development and disease.

Buzz Baum1, Jeffrey Settleman, Margaret P Quinlan.   

Abstract

The ancestors of modern Metazoa were constructed in large part by the foldings and distortions of two-dimensional sheets of epithelial cells. This changed approximately 600 million years ago with the evolution of mesenchymal cells. These cells arise as the result of epithelial cell delamination through a reprogramming process called an epithelial to mesenchymal transition (EMT) [Shook D, Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003;120:1351-83; Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42]. Because mesenchymal cells are free to migrate through the body cavity, the evolution of the mesenchyme opened up new avenues for morphological plasticity, as cells evolved the ability to take up new positions within the embryo and to participate in novel cell-cell interactions; forming new types of internal tissues and organs such as muscle and bone [Thiery JP, Sleeman, JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42; Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-90]. After migrating to a suitable site, mesenchymal cells coalesce and re-polarize to form secondary epithelia, in a so-called mesenchymal-epithelial transition (MET). Such switches between mesenchymal and epithelial states are a frequent feature of Metazoan gastrulation [Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-90] and the neural crest lineage [Duband JL, Monier F, Delannet M, Newgreen D. Epitheliu-mmesenchyme transition during neural crest development. Acta Anat 1995;154:63-78]. Significantly, however, when hijacked during the development of cancer, the ability of cells to undergo EMT, to leave the primary tumor and to undergo MET at secondary sites can have devastating consequences on the organism, allowing tumor cells derived from epithelia to invade surrounding tissues and spread through the host [Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42; Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-90]. Thus, the molecular and cellular mechanisms underpinning EMT are both an essential feature of Metazoan development and an important area of biomedical research. In this review, we discuss the common molecular and cellular mechanisms involved in EMT in both cases.

Entities:  

Mesh:

Year:  2008        PMID: 18343170     DOI: 10.1016/j.semcdb.2008.02.001

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  158 in total

1.  Isolation and characterization of stem-like cells from a human ovarian cancer cell line.

Authors:  Lijuan Wang; Roman Mezencev; Nathan J Bowen; Lilya V Matyunina; John F McDonald
Journal:  Mol Cell Biochem       Date:  2011-12-09       Impact factor: 3.396

Review 2.  Cellular and molecular processes leading to embryo formation in sponges: evidences for high conservation of processes throughout animal evolution.

Authors:  Alexander V Ereskovsky; Emmanuelle Renard; Carole Borchiellini
Journal:  Dev Genes Evol       Date:  2012-04-29       Impact factor: 0.900

Review 3.  Current state of the development of mesenchymal stem cells into clinically applicable Schwann cell transplants.

Authors:  Yu Pan; Sa Cai
Journal:  Mol Cell Biochem       Date:  2012-07-11       Impact factor: 3.396

4.  Diversity in the molecular and cellular strategies of epithelium-to-mesenchyme transitions: Insights from the neural crest.

Authors:  Jean-Loup Duband
Journal:  Cell Adh Migr       Date:  2010-07-27       Impact factor: 3.405

5.  Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines.

Authors:  Modjtaba Emadi Baygi; Zahra-Soheila Soheili; Frank Essmann; Abdolkhaleg Deezagi; Rainer Engers; Wolfgang Goering; Wolfgang A Schulz
Journal:  Tumour Biol       Date:  2010-05-27

6.  Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer.

Authors:  Z Yang; D M Li; Q Xie; D Q Dai
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-26       Impact factor: 4.553

Review 7.  Osteoblast migration in vertebrate bone.

Authors:  Antonia Thiel; Marie K Reumann; Adele Boskey; Johannes Wischmann; Rüdiger von Eisenhart-Rothe; Philipp Mayer-Kuckuk
Journal:  Biol Rev Camb Philos Soc       Date:  2017-06-19

8.  Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells.

Authors:  Kesarin Busaranon; Preeyaporn Plaimee; Boonchoo Sritularak; Pithi Chanvorachote
Journal:  J Nat Med       Date:  2015-09-18       Impact factor: 2.343

9.  Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin.

Authors:  Li-Wu Qian; Whitney Greene; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Reactive oxygen species and tumor metastasis.

Authors:  Doo Jae Lee; Sang Won Kang
Journal:  Mol Cells       Date:  2013-02-21       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.